Bone wax market seen reaching $88.8 billion by 2030

The global bone wax market is projected to grow from $71.16 billion in 2025 to $88.81 billion by 2030, driven by rising surgical volumes and demand for newer hemostatic materials. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Bone wax is a common surgical consumable used to control bleeding from bone surfaces and help surgeons maintain a clear operative field. - The market’s projected growth points to sustained demand across orthopedic, neurosurgical and other procedures as surgical volumes rise. - The shift toward absorbable and bioresorbable materials could change purchasing patterns for hospitals and specialty surgical centers.

What happened: - The Business Research Company said the bone wax market is projected to rise from $71.16 billion in 2025 to $74.41 billion in 2026. - The report forecasts the market will reach $88.81 billion by 2030. - The company projected a 4.6% CAGR from 2025 to 2026 and a 4.5% CAGR through 2030. - The report was released July 29, 2026, from London. - The company published a free sample of the bone wax market report and a full market report.

The details: - The report ties near-term growth to rising orthopedic and neurosurgical interventions, broader use of traditional non-absorbable bone wax, increased surgical capacity in hospitals and greater awareness of bleeding control during operations. - Long-term growth is linked to a rising preference for absorbable hemostatic agents, more minimally invasive procedures, demand for bioresorbable materials, growth in specialty surgical centers and innovation in surgical biomaterials. - Key trends highlighted in the report include absorbable bone wax products, synthetic and biocompatible formulations, infection-reducing hemostatic materials and broader use in specialized surgeries. - Bone wax is described as being primarily made of beeswax, often blended with softening agents such as isopropyl palmitate or petroleum jelly. - The material physically blocks bleeding from bone marrow and cancellous bone surfaces during surgery. - In 2024, the UK Health Security Agency reported that orthopedic operations submitted for mandatory surveillance rose 7.3% from the 2022-2023 financial year, reaching 102,027 operations. - Voluntary surveillance in the UK also increased 13.3% to 23,070 operations. - In 2025, North America held the largest share of the bone wax market. - Asia-Pacific is projected to be the fastest-growing region. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook suggests a transition from older non-absorbable products toward newer absorbable and synthetic alternatives. - Rising surgical volumes are doing more than lifting demand; they are also pushing buyers to favor materials that support efficiency, safety and infection control. - The regional split hints that mature markets remain large, but growth is shifting toward faster-expanding health systems in Asia-Pacific.

What's next: - The report expects continued gains as minimally invasive surgery expands and hospitals adopt more advanced biomaterials. - Specialty surgical centers and new hemostatic products are likely to be key demand drivers over the forecast period. - The company said its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.